ProlactinomaMicroprolactinomasappear asahypodense area on maqneticresonance imaaing.Serum
prolactinuevelsusually correspondtotumoursize.oftenabove3000muuinpatientswith macroadenomas.
ManaqememtFirst-linetherapv
dopamineaaonists
lower prolactin evels.decreasetumour sizeanc
restoregonadaufunctonfor patients harbouring symptomatc prouactin-secreting micro- or macroadenomas.
Caberqoline isused inpreferencetoother dopamineaaonists becausethas hiaher efficacy innormalisinq
prolactinlevels.as weuas ahiaherfreauencyv ofpituitary tumourshrinkaae.Forsvmptomatic patientswhodo
notachievenormauprolactinevelsor show sianificant reductioninumoursizeonstandarddosesofa
dopamineaaonistresistant prolactinomas).thedoseshoudbeincreasedtomaximaltoerabledosesbefore
reserved for symptomatic patients with
referrinqthepatientfor surqery.TranssphenoidaL surgery
prolactinomaswhocannottoleratehiahdosesofcaberaolineor arenotresponsivetodopamineaaonist
therapy.
@1MINENDOCRINE
